Shares of Endo International surged as much as 18 percent after the company named a new CEO and projected upbeat full-year earnings. » Read More
A drugmaker producing acne creams has raised the price of two of its treatments to almost $10K a tube, the Financial Times reports.
Mylan CEO Heather Bresch is set to testify Wednesday before a House committee over sky-high price hikes for lifesaving EpiPens.
Less than 10 percent of authorized doctors prescribe the medication buprenorphine to more than 75 patients.
Shares of Sarepta Therapeutics jumped more than 13 percent in Tuesday trade after closing higher Monday on government approval of its drug.
GlaxoSmithKline said it had chosen its head of consumer health care, Emma Walmsley, as its new CEO, after considering other candidates.
Despite rising Obamacare prices, the total premiums paid in many cases are less than work-based coverage.
Shares of Sarepta Therapeutics briefly surge after the FDA approved its muscular dystrophy drug eteplirsen.
RSV — or respiratory syncytial virus — has been a problem that's thwarted medicine for more than half a century.
Workers are being forced to pay more out of pocket for health care than in the past.
People in consumer-directed health plans tend to pay much more out of pocket for health care than others despite lower use.
Employers may be leery about shifting more health costs to their employees, according to the results from two health benefits surveys.
Republicans want to repeal Obamacare, but millions of people could lose coverage if that happens.
The president dropped by a meeting with insurers Monday, and wrote all insurance companies selling Obamacare plans.
GAO investigators repeatedly managed to enroll fictitious applications in health coverage.
Just 8.6 percent of people lack health insurance now, according to a survey.
Year-to-date EpiPen prescriptions increased over last year even as prices rose.
Get the best of CNBC in your inbox